FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303968045> ?p ?o ?g. }

• W4303968045 endingPage "105" @default.
• W4303968045 startingPage "99" @default.
• W4303968045 abstract "Introduction: Children with Steroid sensitive nephrotic syndrome is associated with lower seroconversion of hepatitis B vaccine due to prolonged period of proteinuria, prolonged period of steroid therapy Objective: The primary aims of this study was to assess the seroconversion rate in children with steroid sensitive nephrotic syndrome (SSNS) who were previously vaccinated against hepatitis B and to compare with the titre of vaccinated healthy children. The secondary aims was to study the association of antiHBs titre in different clinical types of diseases and comparison of persistant antibody titre after prolong post vaccinal duration in both nephritic syndrome and control group. Materials and Methods: This cross sectional study was carried out in the department of Paediatric Nephrology, Bangabandhu Sheikh Mujib Medical University, Dhaka from July 2014 to June 2015. A total of 75 vaccinated Children against hepatitis B aged 1 to 12 years of both sex suffering from steroid sensitive nephrotic syndrome were included in this study. Seventy five healthy children against hepatitis B were taken to compare the immunogenecity of hepatitis B vaccine as comparison group. Result: Out of seventy five children with steroid sensitive nephrotic syndrome (SSNS) 51(68%) were male and 24 (32%) were female. Most of the patients belonged to 2-4 year group (39.6%) and of them 42% had 1st attack. In comparison group most of the healthy children belonged to 2-4 year age group 22(28.2%). In nephrotic syndrome group, majority(57.3%) of the patients with nephrotic syndrome had antibody titre <10 miU/ml( not seroprotected). On the contrary 78.7% healthy control were seroprotected (antibody titre >10 miU/ml)and this difference was significant (p value =<0.001). In nephrotic syndrome group significant titre was present in 2-4 years post vaccinal duration which also declined after 9-10 years post vaccinal duration group . In healthy control group significant titre was present in 2-4 years post vaccinal duration group which also declined gradually after increasing post vaccinal duration. Conclusion: In nephrotic syndrome group significant titre was present in 2-4 years post vaccinal duration which also declined after 9-10 years post vaccinal duration group. In healthy control group significant titre was present in 2-4 years post vaccinal duration group which also declined gradually after increasing post vaccinal duration. Medicine Today 2022 Vol.34(2): 99-105" @default.
• W4303968045 created "2022-10-10" @default.
• W4303968045 creator A5003747664 @default.
• W4303968045 creator A5059613625 @default.
• W4303968045 creator A5078493441 @default.
• W4303968045 date "2022-10-10" @default.
• W4303968045 modified "2023-09-30" @default.
• W4303968045 title "Seroprotection of Hepatitis B in Children with Steroid Sensitive Nephrotic Syndrome" @default.
• W4303968045 doi "https://doi.org/10.3329/medtoday.v34i2.61422" @default.
• W4303968045 hasPublicationYear "2022" @default.
• W4303968045 type Work @default.
• W4303968045 citedByCount "0" @default.
• W4303968045 crossrefType "journal-article" @default.
• W4303968045 hasAuthorship W4303968045A5003747664 @default.
• W4303968045 hasAuthorship W4303968045A5059613625 @default.
• W4303968045 hasAuthorship W4303968045A5078493441 @default.
• W4303968045 hasBestOaLocation W43039680451 @default.
• W4303968045 hasConcept C126322002 @default.
• W4303968045 hasConcept C159654299 @default.
• W4303968045 hasConcept C187212893 @default.
• W4303968045 hasConcept C203014093 @default.
• W4303968045 hasConcept C2776029263 @default.
• W4303968045 hasConcept C2777382497 @default.
• W4303968045 hasConcept C2777451964 @default.
• W4303968045 hasConcept C2778930706 @default.
• W4303968045 hasConcept C32611913 @default.
• W4303968045 hasConcept C71924100 @default.
• W4303968045 hasConcept C90924648 @default.
• W4303968045 hasConceptScore W4303968045C126322002 @default.
• W4303968045 hasConceptScore W4303968045C159654299 @default.
• W4303968045 hasConceptScore W4303968045C187212893 @default.
• W4303968045 hasConceptScore W4303968045C203014093 @default.
• W4303968045 hasConceptScore W4303968045C2776029263 @default.
• W4303968045 hasConceptScore W4303968045C2777382497 @default.
• W4303968045 hasConceptScore W4303968045C2777451964 @default.
• W4303968045 hasConceptScore W4303968045C2778930706 @default.
• W4303968045 hasConceptScore W4303968045C32611913 @default.
• W4303968045 hasConceptScore W4303968045C71924100 @default.
• W4303968045 hasConceptScore W4303968045C90924648 @default.
• W4303968045 hasIssue "2" @default.
• W4303968045 hasLocation W43039680451 @default.
• W4303968045 hasOpenAccess W4303968045 @default.
• W4303968045 hasPrimaryLocation W43039680451 @default.
• W4303968045 hasRelatedWork W1993761770 @default.
• W4303968045 hasRelatedWork W2063657756 @default.
• W4303968045 hasRelatedWork W2089735360 @default.
• W4303968045 hasRelatedWork W2255730965 @default.
• W4303968045 hasRelatedWork W2319702516 @default.
• W4303968045 hasRelatedWork W2419016710 @default.
• W4303968045 hasRelatedWork W2442447657 @default.
• W4303968045 hasRelatedWork W3202566745 @default.
• W4303968045 hasRelatedWork W4303968045 @default.
• W4303968045 hasRelatedWork W4312095391 @default.
• W4303968045 hasVolume "34" @default.
• W4303968045 isParatext "false" @default.
• W4303968045 isRetracted "false" @default.
• W4303968045 workType "article" @default.